Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections

Fig. 4

Graphs showing the change in mean intraocular pressure (IOP, a) best-corrected visual acuity (BCVA, b), and central macular thickness (CMT, c) in triamcinolone, dexamethasone implant, and bevacizumab groups on monthly follow-up visits. Asterisks indicate statistically significant differences between baseline and follow-up visits

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us